NEU 3.32% $20.52 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1152

  1. 5,756 Posts.
    lightbulb Created with Sketch. 308
    So an internal DCF valuation by NEU is irrelevant regarding a TO due to current share price at the time?
    Despite them saying its valuation, for a TO, will be based on a DCF ?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.